SNY Sanofi

Sanofi earnings company data as of 7:06 PM ET 10/30

History

1 period, newest first. Each row shows EPS above revenue.

Period	Date	Metric	Estimate	Actual	Result
FY2026 Q3	30 Oct	EPS	1.72	—	—
FY2026 Q3	30 Oct	Rev	$13.28B	$14.44B	Beat +8.8%

Recent issuer filings from EDGAR, 25 shown.

Filed	Form	Detail	Links
Oct 30, 2026	6-K		Filing Doc
Oct 26, 2026	SCHEDULE 13G/A	—	Filing Doc
Oct 26, 2026	6-K		Filing Doc
Oct 1, 2026	6-K		Filing Doc
Sep 17, 2026	6-K		Filing Doc
Aug 6, 2026	6-K		Filing Doc
Jul 30, 2026	6-K		Filing Doc
Jul 30, 2026	6-K		Filing Doc
Jul 27, 2026	6-K		Filing Doc
Jul 22, 2026	SCHEDULE 13G/A	—	Filing Doc
Jul 17, 2026	6-K		Filing Doc
Jul 7, 2026	6-K		Filing Doc
Jun 24, 2026	6-K		Filing Doc
Jun 22, 2026	6-K		Filing Doc
Jun 12, 2026	6-K		Filing Doc
Jun 8, 2026	6-K		Filing Doc
May 27, 2026	6-K		Filing Doc
May 6, 2026	SCHEDULE 13G	—	Filing Doc
May 5, 2026	6-K		Filing Doc
Apr 29, 2026	6-K		Filing Doc
Apr 27, 2026	6-K		Filing Doc
Apr 23, 2026	6-K		Filing Doc
Apr 15, 2026	6-K		Filing Doc
Apr 10, 2026	SCHEDULE 13G/A	—	Filing Doc
Mar 31, 2026	6-K		Filing Doc

Forms 3, 4 and 5 from EDGAR, 2 rows shown

Filed	Form	Detail	Links
Aug 12, 2026	4	Period Aug 10, 2026	Filing Doc
Aug 7, 2026	4	Period Aug 6, 2026	Filing Doc

Source: SEC EDGAR submissions, updated about 11 hours ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.